애드바이오텍

179530KOSDAQ

47.5 / 100

Reference Date: 2026-10-23

Financial Score17.0 / 40

News Sentiment12.5 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 3.2% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

AdvaTek is a biotech company developing eco-friendly products for livestock, aquaculture, and human use through technologies like IgY immune yolk antibodies, VHH nanobody antibodies, and microbial agents. Its IgY technology offers high titer and thermal stability, while VHH nanobodies provide strong tissue penetration and easy mass production, positioning them as promising alternatives to antibiotics and vaccines.

Number of Employees

64people

Average Salary

42.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

4.82Industry Average 1.200.0Point

4.0x industry avg (risky)

ROE

-40.31Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

25.03Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲11.1% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲14.3% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -70.2% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (28%)

Current 2,095Won52-week high 3,94552-week low 1,350

1-month return4.0Point

1m +3.20% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0